Boston Scientific (BSX) Competitors $104.48 +1.29 (+1.25%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STEShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Boston Scientific vs. Abbott Laboratories Intuitive Surgical Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Do analysts rate ABT or BSX? Abbott Laboratories presently has a consensus price target of $142.59, indicating a potential upside of 8.88%. Boston Scientific has a consensus price target of $114.52, indicating a potential upside of 11.01%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than Abbott Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.84Boston Scientific 0 Sell rating(s) 0 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 3.04 Which has preferable valuation and earnings, ABT or BSX? Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.95B5.41$13.40B$7.7116.99Boston Scientific$17.55B8.69$1.85B$1.3775.30 Do insiders & institutionals have more ownership in ABT or BSX? 75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.5% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ABT or BSX more profitable? Abbott Laboratories has a net margin of 31.95% compared to Boston Scientific's net margin of 11.07%. Abbott Laboratories' return on equity of 20.74% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories31.95% 20.74% 11.19% Boston Scientific 11.07%17.80%9.85% Does the media refer more to ABT or BSX? In the previous week, Abbott Laboratories had 10 more articles in the media than Boston Scientific. MarketBeat recorded 49 mentions for Abbott Laboratories and 39 mentions for Boston Scientific. Abbott Laboratories' average media sentiment score of 1.27 beat Boston Scientific's score of 1.05 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 38 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 23 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ABT or BSX? Abbott Laboratories has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500. Does the MarketBeat Community believe in ABT or BSX? Boston Scientific received 114 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 70.00% of users gave Abbott Laboratories an outperform vote while only 69.90% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes95270.00% Underperform Votes40830.00% Boston ScientificOutperform Votes106669.90% Underperform Votes45930.10% SummaryAbbott Laboratories beats Boston Scientific on 10 of the 18 factors compared between the two stocks. Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$152.59B$4.33B$5.53B$18.96BDividend YieldN/A39.93%5.11%4.01%P/E Ratio82.5330.0322.5932.87Price / Sales8.6955.31401.3528.03Price / Cash28.8651.0838.1817.52Price / Book6.926.056.774.47Net Income$1.85B$68.71M$3.22B$1.02B7 Day Performance1.18%-0.24%1.39%0.59%1 Month Performance3.09%-2.90%2.78%-3.54%1 Year Performance43.22%21.00%15.85%3.80% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.0983 of 5 stars$104.48+1.2%$114.52+9.6%+42.9%$154.66B$17.55B83.6545,000Analyst UpgradePositive NewsABTAbbott Laboratories4.8949 of 5 stars$129.73+0.7%$142.59+9.9%+23.2%$224.89B$41.95B16.95115,000Positive NewsISRGIntuitive Surgical4.6185 of 5 stars$514.65+0.0%$598.95+16.4%+39.1%$183.33B$8.71B80.3012,100Insider TradeSYKStryker4.8203 of 5 stars$367.19+0.6%$423.53+15.3%+14.1%$140.18B$22.60B47.3351,000Earnings ReportPositive NewsMDTMedtronic4.5496 of 5 stars$84.07-0.1%$96.14+14.4%+3.1%$107.82B$33.20B25.5595,000Positive NewsBDXBecton, Dickinson and Company4.9595 of 5 stars$205.020.0%$272.86+33.1%-27.5%$58.90B$20.64B34.0877,000Earnings ReportDividend AnnouncementAnalyst DowngradeNews CoverageGap DownEWEdwards Lifesciences4.6129 of 5 stars$75.55-0.6%$79.45+5.2%-10.6%$44.37B$5.25B10.8317,300Short Interest ↓Positive NewsIDXXIDEXX Laboratories4.0405 of 5 stars$435.59-0.4%$523.75+20.2%+0.7%$35.24B$3.90B40.7510,800Upcoming EarningsPositive NewsRMDResMed4.0455 of 5 stars$234.07-0.8%$258.83+10.6%+9.9%$34.40B$5.02B27.658,160Analyst UpgradePositive NewsDXCMDexCom4.9112 of 5 stars$71.28-0.5%$99.00+38.9%-44.2%$27.98B$4.03B49.907,600Earnings ReportNews CoveragePositive NewsSTESTERIS4.5034 of 5 stars$225.97+0.4%$258.75+14.5%+8.4%$22.17B$5.40B47.9116,000Upcoming EarningsShort Interest ↑Positive News Related Companies and Tools Related Companies Abbott Laboratories Alternatives Intuitive Surgical Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BSX) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.